PrairieView Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$45K Hold
163
﹤0.01% 196
2025
Q1
$50K Sell
163
-16
-9% -$4.72K 0.01% 187
2024
Q4
$46K Buy
179
+97
+118% +$28.8K ﹤0.01% 202
2024
Q3
$26K Hold
82
﹤0.01% 231
2024
Q2
$25K Hold
82
﹤0.01% 242
2024
Q1
$24K Sell
82
-1
-1% -$293 ﹤0.01% 229
2023
Q4
$24K Sell
83
-42
-34% -$11.4K ﹤0.01% 222
2023
Q3
$33K Sell
125
-15
-11% -$3.74K ﹤0.01% 204
2023
Q2
$31K Buy
140
+100
+250% +$23.2K ﹤0.01% 231
2023
Q1
$9K Sell
40
-6
-13% -$1.47K ﹤0.01% 309
2022
Q4
$12K Buy
46
+20
+77% +$5.36K ﹤0.01% 299
2022
Q3
$6K Hold
26
﹤0.01% 336
2022
Q2
$6K Hold
26
﹤0.01% 355
2022
Q1
$6K Buy
+26
New +$5.97K ﹤0.01% 351

Other funds holding AMGN

PrairieView Partners's AMGN Position: Q2 2025 in Review

PrairieView Partners held its Amgen (AMGN) position steady in Q2 2025 at 163 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #196.

PrairieView Partners first reported a position in AMGN in Q1 2022 and has held it in 14 quarters since. The position peaked at $50K in Q1 2025. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • PrairieView Partners held 163 shares of Amgen worth $45K as of Q2 2025.
  • PrairieView Partners left its Amgen share count unchanged in Q2 2025.
  • Amgen made up ﹤0.01% of PrairieView Partners's portfolio in Q2 2025, its #196 holding.
  • PrairieView Partners first reported a position in Amgen in Q1 2022 and has held it in 14 quarters since.
  • PrairieView Partners's Amgen position peaked at $50K in Q1 2025.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.